Rotundic acid is an orally effective triterpenoid with a Kd value of 51.3 µM for PTP1B. Rotundic acid downregulates the AKT/mTOR pro-survival pathway and modulates the MAPK pathway. Rotundic acid induces cell cycle S-phase arrest, DNA damage and apoptosis, it inhibits migration, invasion, angiogenesis and proliferation of cancer cells. Rotundic acid improves leptin sensitivity, regulates gut microbiota and reduces cellular senescence. Rotundic acid can be used in research related to hepatocellular carcinoma, obesity, aging, acute lung injury and type 2 diabetes[1][2][3][4].
Molecular Weight:
488.70
Purity:
99.41
CAS Number:
[20137-37-5]
Formula:
C30H48O5
Target:
Akt,Apoptosis,Heme Oxygenase (HO),Interleukin Related,Keap1-Nrf2,mTOR,NF-kappaB,p38 MAPK,Phosphatase,PI3K,Reactive Oxygen Species (ROS),Toll-like Receptor (TLR)
Application Notes:
MCE Product type: Natural Products
* VAT and and shipping costs not included. Errors and price changes excepted
